Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

ORA Research News - Monday, September 23, 2019

Reminder of NIH Policies on Other Support and on Policies related to Financial Conflicts of Interest

and Foreign Components

On July 10, 2019, NIH released an announcement on “Reminders of NIH Policies on Other Support and on Policies

related to Financial Conflicts of Interest and Foreign Components” to remind the extramural community about the

need to report foreign activities through documentation of other support, foreign components, and financial conflict

of interest to prevent scientific, budgetary, or commitment overlap. NIH has long required full transparency for all

research activities both domestic and foreign and does not consider these clarifications to be changes in policy. 

All faculty are encouraged to go to the following link as a reminder of this policy:



Reference Letters vs. Letters of Support: What’s the Difference?

Reference letters and letters of support provide key information for reviewers and NIH staff. Check out the attached

table for an overview of when each letter is used, who writes them, and what should be included. Letters vs.pdf?ver=2019-09-23-075716-940


i2E Entrepreneurial Summit on Friday, November 15, 2019 at 9:00 am – 1:00 pm at the Reed Conference

Center, Midwest City 73110.  See attached document for more complete information.


Don’t Forget to Link Your ORCID iD to Your eRA Commons Profile

Graduate students to senior scientists are encouraged to register for an ORCID account (

and link it to their eRA Commons personal profile


Starting October 1, 2019, ORCID identifiers will be required for individuals supported by institutional research training,

career development, and other research education awards. xTrain appointments will not be accepted for agency review

if potential appointees do not have an ORCID iD linked to their eRA personal profile. ORCID iDs will also be required for

PD/PIs on individual fellowship and career development applications submitted for due dates on or after January 25, 2020.



The Office of Technology Development will offer the Innovation to Impact Series Session 2  

“Aligning Your Research With Industry.” Learn how to gather useful insights from the market; Common customer discovery

mistakes; and Funding to support market discovery. Meredith Wilkerson, Licensing Officer -Life Sciences and Andrew

Pollock, Interim Exec. Director of OTD will be presenting.

This session will occur on September 25th  from Noon- 1:00 pm in Biomedical Research Center Building,  Room 103.

Lunch will be provided.

Please RSVP to by September 23rd. Space is limited to the first 15 attendees.



National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), Small

Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) experts are c

oming to Oklahoma City to conduct an SBIR Outreach Event.

Wednesday, September 25th from 9:00 am to 4:00 pm at the OUHSC PHF Conference Center. 

See the attached document for additional information. Contract SBIR Topics.docx?ver=2019-08-18-153311-077


Office of Technology Development presents a third opportunity to engage with industry

(for more information go to, or email for specific submission details):

Almirall is looking to sponsor academic research for target identification, validation, and/or to advance pre-clinical therapeutic

opportunities into clinical settings for “novel targets, pathways, or therapeutic candidates relating to chronic immune-inflammatory

disease” (expiration 9/30/19).  Funding up to $250K per project to be awarded by Almirall in November 2019.



Harold Hamm Diabetes Center (HHDC) Research Symposium CALL FOR ABSTRACTS 

The abstract submission deadline for the HHDC 2019 Research Symposium is Friday, October 4th. Abstracts must be

received by 5 p.m. HHDC 2019 Research Symposium will be held on Friday, November 15, 2019 at the Samis Education

Center in Children’s Hospital in Oklahoma City. The Symposium will consist of selected oral presentations, a poster session,

and Symposia talks by P. Darrell Neufer, PhD, Professor, East Carolina University, Matthew Rodeheffer PhD, Associate

Professor, Yale University and Scott Summers, PhD, Professor and Chair, The University of Utah.  For abstract submission

guidelines and to RSVP for this free event, please go to:  

Please contact with any questions for this event.



Save the Date – ORA Noon Conference

Navigating the ORA Proposal Submission Process

Speaker(s):       Caitlin Novotny, Sponsored Programs Administrator, Office of Research Administration

Offered:             September 25, 2019  LIB-299 12-1pm

Overview:          This session will cover the basics of proposal preparation and map out the process of submission through

the Office of Research Administration. We will discuss what your Sponsored Programs Administrator looks for during the

pre-award review, such as budget considerations, eligibility, and compliance with applicable rules and policies. We will

also cover topics related to proposal submission, such as grant routing forms and the systems used to submit federal grants.

The overall goal of this presentation is to provide a basic understanding of and advice on proposal preparation and submission




Notice of Pre-Application Webinar for FOAs related to the NHLBI CATALYZE Program: RFA-HL-20-022, RFA-HL-20-023,

RFA-HL-20-024, RFA-HL-20-027 and RFA-HL-20-028 (NOT-HL-19-709)


AHRQ Encourages Use of Fast Healthcare Interoperability Resources (FHIR) Standard (NOT-HS-19-020)


HEAL/NINDS Early Phase Pain Investigation Clinical Network (EPPIC-Net): Opening to applications for non-addictive pain

therapeutics (NOT-NS-19-075)


New to Working with the NIH Grants Process & Policies? Dont Miss the NIH Regional Seminar on Program Funding and

Grants Administration Phoenix, AZ Nov. 6-8, 2019 (NOT-OD-19-144)


Request for Information (RFI) on the Lessons Learned from the Accelerating Medicines Partnership Rheumatoid Arthritis

and Lupus (AMP RA/SLE Program (NOT-AR-19-039)


Request for Information (RFI): Inviting comments and suggestions on the development of a prize competition for Gender

Diversity in the Biomedical Research Workforce (NOT-OD-19-141)

Request for Information (RFI): Enhancing the Clinical and Translational Science Awards (CTSA) Program


NIDDK Notice of Participation in PA-19-273, "PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small

Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)"


Notice of Clarification of Eligible Individuals for RFA-DK-18-024 "Predoctoral to Postdoctoral Fellow Transition Award

(F99/K00)" (NOT-DK-19-025)


Notice of Clarification of Research Strategy for RFA-DK-19-010 Polycystic Kidney Disease (PKD) Research and Translation

Core Centers" (NOT-DK-19-026)


Notice of NIBIB's Participation in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers

(MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)"



Notice of Change of Receipt Date for RFA-HD-20-007 "The Role of Stem/Progenitor Cells in the Pathogenesis and

Treatment of Gynecologic Disorders (R21 Clinical Trial Optional)" (NOT-HD-19-026)


Notice of Intent to Publish a Funding Opportunity Announcement for Early Liver Transplantation Cohort Study

(U10 - Clinical Trial Optional) (NOT-AA-19-025)


Notice of Special Interest in High Priority Research Areas for Sex and Gender Influences on the Adolescent Brain and

the Mental Health of Girls and Young Women (Ages 12-24) (NOT-MH-19-039)



Please Note:  When only one application is allowed per Institution according to the sponsor

instructions, a one-page letter of intent summarizing the proposed project should be submitted

to the Vice President for Research at least one month prior to the application deadline (unless

otherwise noted).  The letters of intent will be reviewed and a single application will be chosen  

for submission from the University.




Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)

(PAR-19-365) - Deadline


Institutional Research and Academic Career Development Awards (IRACDA) (K12 - Independent Clinical Trial Not Allowed)

(PAR-19-366) – Deadline November 13, 2019 and October 1, 2020


Maximizing Investigators' Research Award (R35 - Clinical Trial Optional) (PAR-19-367)
Deadline January 17, 2020 and May 18, 2020

Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)
(PAR-19-368) - Deadline October 5, 2019


Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed) (PAR-19-369)

Deadline October 16, 2019.


NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed) (PAR-19-370)
Deadline October 16, 2019.


NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) (PAR-19-371)
Deadline October 12, 2019


Social Epigenomics Research Focused on Minority Health and Health Disparities (R01-Clinical Trial Not Allowed) (PAR-19-372)

Deadline November 6, 2019 and November 6, 2020


Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)
(PAR-19-374) - Deadline January 25, 2020


Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed)

(PAR-19-375) - Deadline February 16, 2020


Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional) (PAR-19-376)

Deadline November 19, 2019 and September 24, 2020


Omics-guided Biobehavioral Interventions for Improved Health Outcomes: A Step Forward in Translation

(R01 Clinical Trial Optional) (PAR-19-377) - Deadline February 5, 2020


MD-PhD Training Program in Alzheimer's Disease and Related Dementias and the Behavioral and Social Sciences

(T32 Clinical Trial Not Allowed) (RFA-AG-20-032) – Deadline October 28, 2019


Tailoring Interventions to Improve Preventive Health Service Use (R61/R33 Clinical Trial Required)
(RFA-AG-20-045) - Deadline November 4, 2019


Advancing Sustained/Extended Release for HIV Prevention (A-SER) (R01 Clinical Trial Not Allowed)
(RFA-AI-19-063) – Deadline AIDS


Informatics Technology for Cancer Research Education Center (UE5 Clinical Trials Not Allowed)
(RFA-CA-19-042) - Deadline December 19, 2019 and July31, 2020


Limited Competition: AIDS Malignancy Consortium (AMC) (UM1 Clinical Trials Required)
(RFA-CA-19-056) – Deadline January 10, 2020


Improving the Reach and Quality of Cancer Care in Rural Populations (R01 Clinical Trial Required)
(RFA-CA-19-064) - Deadline January 15, 2020


The Rat Opioid Genome Project: Clinical Trials not Allowed (U01- Clinical Trial Not Allowed)
(RFA-DA-20-010) - Deadline November 19, 2019


NIDDK Cooperative Centers of Excellence in Hematology (U54 Clinical Trial Not Allowed)
(RFA-DK-19-005) - Deadline November 21, 2019 and June 30, 2020


Data Sharing for Demographic Research Infrastructure Program (R24 Clinical Trial Not Allowed)
(RFA-HD-20-001) - Deadline November 29, 2019


Fertility and Fertility Preservation for Patients with Diseases that Previously Precluded Reproduction

(R21 Clinical Trial Optional) (RFA-HD-20-021) – Deadline November 26, 2019


Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38) (Clinical Trial Not Allowed)

(RFA-HL-20-006) - Deadline November 18, 2019 and October 15, 2020


Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
(RFA-HL-20-022) - Deadline November 8, 2019 and March 9, 2020


Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary

Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) (RFA-HL-20-023)
Deadline November 8, 2019 and March 9, 2020


Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay

Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed)
(RFA-HL-20-024) - Deadline November 8, 2019 and March 9, 2020


Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification

(R33 - Clinical Trial Not Allowed) (RFA-HL-20-027) – Deadline November 8, 2019 and March 9, 2020


Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay

Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed)

(RFA-HL-20-028) - Deadline November 8, 2019 and March 9, 2020


Bench to Bassinet Program Administrative Coordinating Center (U01 - Clinical Trial Not Allowed)
(RFA-HL-21-002) - Deadline March 6, 2020

Resource-Related Research Projects for Development of Animal Models and Related Materials

(R24 Clinical Trials Not-Allowed) (RFA-OD-19-027) - Deadline October 28, 2019 and January 27, 2020





American Cancer Society (ACS) – Deadline October 15, 2019 – Programs:

            Research Scholar Grants

            Clinician Scientist Development Grant

Postdoctoral Fellowship